SNOA - Sonoma Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
3/31/2019
3/31/2018
3/31/2017
Total Revenue
18,739
18,970
16,658
12,825
Cost of Revenue
10,045
10,090
9,348
7,157
Gross Profit
8,694
8,880
7,310
5,668
Operating Expenses
Research Development
1,183
1,518
1,575
1,576
Selling General and Administrative
14,129
18,620
19,924
17,066
Total Operating Expenses
15,312
20,138
21,499
18,642
Operating Income or Loss
-6,618
-11,258
-14,189
-12,974
Interest Expense
20
33
40
3
Total Other Income/Expenses Net
2,134
-239
-357
18
Income Before Tax
-4,336
-11,340
-14,328
-12,937
Income Tax Expense
-
458
0
-4,268
Income from Continuing Operations
-4,794
-11,798
-14,328
-8,669
Net Income
-4,794
-11,798
-14,328
9,274
Net Income available to common shareholders
-4,794
-11,798
-14,328
9,274
Basic EPS
-
-12.77
-28.44
19.53
Diluted EPS
-
-12.77
-28.44
19.53
Basic Average Shares
-
923.999
503.332
474.443
Diluted Average Shares
-
923.999
503.332
474.443
EBITDA
-
-10,854
-13,798
-12,686